Treatment option guidelines for lung cancer Flashcards
SMALL CELL LUNG CANCER
Treatment Guidelines- SCLC
early stage /localized disease
T1/2 N0 M0
Surgery if resectable
Post op chemotherapy
patients should be considered for PCI if they have a response to initial treatment.
treatment guidelines-SCLC
Early stage/localised disease T1-4 N0-3 M0
-concurrent CRT (sequential if PS is worse)
-Thoracic RT should be initiated as early as possible (starting with the 1st/2nd cycle of chemo)
– Elective nodal irradiation depends on staging (PET +/- biopsy)
NON SMALL CELL LUNG CANCER
Treatment Guidelines- NSCLC
early staged disease (stage I and II)
surgery
NOT POSSIBLE = SABR
BED ≥100Gy
SABR:
Common fractionations used in ireland are
60Gy/3#,
60Gy/5#,
60Gy/8#
34Gy/1#
Treatment Guidelines- NSCLC
locally advanced stage disease (stage II-III)…. (N1-3) pt1
-IF Unresectable ….treated with CCRT
(66Gy in 33#)
-Cisplatin chemo recommended
-RT delivery should not exceed 7 weeks
Treatment Guidelines- NSCLC
locally advanced stage disease (stage II-III)…. (N1-3) pt2
-patient not fit for CCRT=sequential accelerated RT schedules are recommended e.g. 66Gy/24#
-Consolidation Immunotherapy (to kill any cancer cells left in the body)
Treatment Guidelines- NSCLC- Immunotherapy
locally advanced stage disease
In Lung often are Immune checkpoint inhibitors: basically take the ‘brakes’ off the immune system, which helps attack cancer cells. (PD1 and PDL1 )
Treatment Guidelines- NSCLC
Metastatic Disease (Stage IV)
PALLIATIVE INTENT
systematic therapy is recommended
Chemotherapy OR
Targeted therapy/Immunotherapy if indicated -
EGFR mutated/ALK mutated/PD-L1 etc
Metastatic Disease (Stage IV)
Role of Radiotherapy
– Symptom relief for
* Bone Pain
* Haemoptysis (coughing blood)
* SVCO
– Brain Mets: SRS for limited number of mets, WBRT if more 20Gy/5# or 30Gy/10#
Metastatic Disease (Stage IV)
Tx N0 M1a=
contralateral lung, solitary nodule, no Nodes
Treat both a primary
NSCLC
Oligometastatic Disease (Stage IV)
Systemic therapy and a radical local treatment (SABR/Surgery)
NSCLC Overview
-early stage
-locally advanced
-Surgery or SABR
-ChemoRT (60-66Gy/30-33#) preferably concurrent+condsilation IO
if not fit for concurrent , sequential and accelerated RT (66Gy/24#)
NSCLC Overview
Metastatic
Oligometastatic-Systemic treatment and SABR
More extensive Metastases- Systemic therapy (TT/IO/CT) and palliative RT if indicated